Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Radiation Research|September 10, 2025
Trends in Dose to the Contralateral Breast from Breast Cancer Radiotherapy in the United StatesChoonsik Lee, David Borrego, Lene H S Veiga, et al.
Journal of Personalized Medicine|November 27, 2021
Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study ProtocolTia L Kauffman, Yolanda K Prado, Ana A Reyes, et al.
Journal of the National Cancer Institute|September 6, 2012
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort studyErin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, et al.
Genetics in Medicine Open|December 13, 2024
Feasibility of an electronic patient-facing cancer family history tool in medically underserved populationsHeather Spencer Feigelson, Kathleen F Mittendorf, Sonia Okuyama, et al.
JCO Clinical Cancer Informatics|September 6, 2019
Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research NetworkAndrea N Burnett-Hartman, Natalia Udaltsova, Lawrence H Kushi, et al.
BMC Cancer|February 26, 2022
The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorshipHeather Spencer Feigelson, Christina L Clarke, Stephen K Van Den Eeden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2012
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settingsJennifer Webster, Tia L Kauffman, Heather Spencer Feigelson, et al.
British Journal of Cancer|November 14, 2025
Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivorsLene H S Veiga, Gretchen L Gierach, Susan A Smith, et al.
Familial Cancer|March 23, 2021
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse populationKathleen F Mittendorf, Chinedu Ukaegbu, Marian J Gilmore, et al.
Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.
Pageof 13